Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer

被引:50
|
作者
Yuh, Bertram E. [1 ]
Ruel, Nora H. [1 ]
Mejia, Rosa [1 ]
Wilson, Chelsea M. [1 ]
Wilson, Timothy G. [1 ]
机构
[1] City Hope Natl Canc Ctr, Duarte, CA 90017 USA
关键词
Pelvic lymphadenectomy; Robotics; Positive lymph nodes; Prostate Cancer; LYMPH-NODE DISSECTION; RADICAL PROSTATECTOMY; IMPACT; METASTASES; MEN; YIELD;
D O I
10.1016/j.eururo.2012.01.048
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Accurate staging of prostate cancer is enhanced by a thorough evaluation of the pelvic lymph nodes. Limited data are available regarding robotic extended pelvic lymphadenectomy (PLA) in this setting. Objective: Analyze our experience performing robotic extended PLA. Design, setting, and participants: A total of 143 consecutive men with intermediate-or high-risk clinically localized adenocarcinoma of the prostate underwent robotic extended PLA and radical prostatectomy between September 2010 and November 2011 by a single surgeon. Surgical procedure: Lymph node packets were sent separately from bilateral common, external, and internal iliacs, obturators, node of Cloquet, and anterior prostatic fat. Measurements: Descriptive statistics were used to summarize lymph node yields and positive nodes. Clinical variables were examined in logistic regression models to predict lymph node positivity. Results and limitations: Median lymph node yield was 20 (range: 9-65, interquartile range: 15-25). Eighteen patients (13%) were found to have metastatic prostate cancer in the lymph nodes. The mean number of positive nodes foundwas 2.9 (range: 1-11). In 14 of 18 node-positive patients (78%), the extent of nodal invasion was outside the boundaries of a limited PLA. For four patients with positive nodes (22%), prostate biopsy predicted unilateral disease but PLA revealed contralateral positive lymph nodes. A total of 82% of patients experienced no complications, and most Clavien grade 1-2 complications consisted of anastomotic leakage, urinary retention, ileus, and lymphocele. Only 4% of patients experienced a grade 3 complication. Under multivariate regression analysis, prostate-specific antigen (PSA), clinical stage, and maximum biopsy core tumor volume were identified as significant predictors of finding positive pelvic lymph nodes (area under the curve: 91%). The main limitations include short follow-up and lack of randomization. Conclusions: Robotic extended bilateral PLA for prostate cancer up to the common iliac bifurcation increases nodal yield and positive nodal rate and can be performed safely. PSA, clinical stage, and maximum biopsy core volume are predictors for lymph node invasion. Long-term follow-up is needed to evaluate for therapeutic benefit. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1004 / 1010
页数:7
相关论文
共 50 条
  • [1] Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer
    Eden, Christopher G.
    Arora, Avanish
    Rouse, Paul
    BJU INTERNATIONAL, 2010, 106 (04) : 537 - 542
  • [2] The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines
    Eden, Christopher G.
    Zacharakis, Evangelos
    Bott, Simon
    BJU INTERNATIONAL, 2013, 112 (03) : 346 - 354
  • [3] Intermediate and high risk prostate cancer patients. Clinical significance of extended lymphadenectomy
    Osmonov, D. K.
    Boller, A.
    Aksenov, A.
    Naumann, M.
    Juenemann, K. P.
    UROLOGE, 2013, 52 (02): : 240 - 245
  • [4] The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer
    Harbin, Andrew C.
    Eun, Daniel D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (05) : 208 - 216
  • [5] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +
  • [6] Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study)
    Lannes, Francois
    Baboudjian, Michael
    Ruffion, Alain
    Rouy, Mathieu
    Giammarile, Francesco
    Rousseau, Thierry
    Kraeber-Bodere, Francoise
    Rousseau, Caroline
    Rusu, Daniela
    Colombie, Mathilde
    Brenot-Rossi, Isabelle
    Rossi, Dominique
    Mottet, Nicolas
    Bastide, Cyrille
    JOURNAL OF UROLOGY, 2023, 209 (02) : 364 - 372
  • [7] Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer
    Zumsteg, Zachary S.
    Zelefsky, Michael J.
    Woo, Kaitlin M.
    Spratt, Daniel E.
    Kollmeier, Marisa A.
    McBride, Sean
    Pei, Xin
    Sandler, Howard M.
    Zhang, Zhigang
    BJU INTERNATIONAL, 2017, 120 (5B) : E87 - E95
  • [8] Molecular correlates of intermediate- and high-risk localized prostate cancer
    Ye, Huihui
    Sowalsky, Adam G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 368 - 374
  • [9] Focal therapy in intermediate- and high-risk prostate cancer
    Nicolai A. Huebner
    Stephan Korn
    Pawel Rajwa
    Shahrokh F. Shariat
    memo - Magazine of European Medical Oncology, 2023, 16 : 247 - 250
  • [10] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250